Pharm Exec’s Top 50 Pharma Companies — in Brief The vigorous return of M&A activity to biopharmaceuticals this year begs the question: is more size and scalable efficiencies the best solution to the declining market power of pharmaceuticals in an endlessly restructuring healthcare system? Our latest annual iteration of the Pharma 50 rankings confirms that the answer to this is ‘no’...Read more
Pharma Top 50 Trends — Past, Present and Future Finding the correct coordinates for Big Pharma's endless cycle of re-positioning is just as important as a winning scientific hand, writes Pharm Exec Editor-in-Chief William Looney ... Read more
Transparency in Europe: The New Pharm Exec Global Digest In this month’s Pharm Exec Global Digest digital magazine: Staying Ahead of the Transparency Curve in Europe; Clinical Trials in Europe — the Die is Cast; Preparing for 2016’s Clinical Trials Regulations; the European Medicines Agency's Transparency Dilemma; and more... Read more
Product Cycle Strategies for Greater Profitability In this compilation of four in-depth, data-rich reports from Pharmaceutical Executive, you'll learn a new set of metrics allowing companies to align their strategies around the push for greater profitability, putting them on the right track ... Click here to order
